1. Home
  2. XELB vs PHGE Comparison

XELB vs PHGE Comparison

Compare XELB & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.54

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$6.72

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
PHGE
Founded
2011
2015
Country
United States
United States
Employees
N/A
57
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
7.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
XELB
PHGE
Price
$1.54
$6.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$26.00
AVG Volume (30 Days)
39.7K
82.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.25
52 Week High
$4.52
$8.50

Technical Indicators

Market Signals
Indicator
XELB
PHGE
Relative Strength Index (RSI) 47.87 62.96
Support Level $1.38 $0.41
Resistance Level $1.60 $8.50
Average True Range (ATR) 0.21 0.78
MACD -0.05 0.08
Stochastic Oscillator 22.08 84.59

Price Performance

Historical Comparison
XELB
PHGE

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: